(2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide

C155H204N14O28S — CID 159563569

IUPAC(2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide
SMILESCC(C)(C)O.CC(C)(C)O.CC(C)(C)O.CC(C)(C)O.CC(C)(C)O.COC[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)CCc1ccccc1)C(=O)CCc1cccc2ccccc12.C[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)CCc1ccccc1)C(=O)CCc1cccc2[nH]ccc12.C[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)CN1CCOCC1)C(=O)CCc1cccc2ccccc12.C[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)c1cnccn1)C(=O)CCc1cccc2ccccc12.Cc1ccc(S(=O)(=O)C[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)CCc2cccc3ccccc23)cc1
InChIInChI=1S/C30H34N2O5.C27H31N3O4.C27H30N2O5S.C26H33N3O5.C25H26N4O4.5C4H10O/c1-37-20-27(28(34)17-15-23-12-7-11-22-10-5-6-13-26(22)23)32-30(36)24(19-29(31)35)18-25(33)16-14-21-8-3-2-4-9-21;1-18(25(32)13-11-20-8-5-9-24-23(20)14-15-29-24)30-27(34)21(17-26(28)33)16-22(31)12-10-19-6-3-2-4-7-19;1-18-10-13-23(14-11-18)35(33,34)17-22(16-26(28)31)27(32)29-19(2)25(30)15-12-21-8-5-7-20-6-3-4-9-24(20)21;1-18(24(31)10-9-20-7-4-6-19-5-2-3-8-23(19)20)28-26(33)21(16-25(27)32)15-22(30)17-29-11-13-34-14-12-29;1-16(22(30)10-9-18-7-4-6-17-5-2-3-8-20(17)18)29-25(33)19(14-24(26)32)13-23(31)21-15-27-11-12-28-21;5*1-4(2,3)5/h2-13,24,27H,14-20H2,1H3,(H2,31,35)(H,32,36);2-9,14-15,18,21,29H,10-13,16-17H2,1H3,(H2,28,33)(H,30,34);3-11,13-14,19,22H,12,15-17H2,1-2H3,(H2,28,31)(H,29,32);2-8,18,21H,9-17H2,1H3,(H2,27,32)(H,28,33);2-8,11-12,15-16,19H,9-10,13-14H2,1H3,(H2,26,32)(H,29,33);5*5H,1-3H3/t24-,27-;18-,21-;19-,22+;18-,21-;16-,19-;;;;;/m00000...../s1
InChIKeyMGXQYNQOYHIQCE-BNWQGVBUSA-N
MW2743.47 g/mol
LogP17.85
Rot. Bonds62

About (2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide

(2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide (PubChem CID 159563569) has the molecular formula C155H204N14O28S and a molecular weight of 2743.47 g/mol. Its IUPAC name is (2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide.

Molecular Properties

Compound Name(2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide
PubChem CID159563569
Molecular FormulaC155H204N14O28S
Molecular Weight2743.47 g/mol
Exact Mass2741.47
IUPAC Name(2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide
SMILESCC(C)(C)O.CC(C)(C)O.CC(C)(C)O.CC(C)(C)O.CC(C)(C)O.COC[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)CCc1ccccc1)C(=O)CCc1cccc2ccccc12.C[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)CCc1ccccc1)C(=O)CCc1cccc2[nH]ccc12.C[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)CN1CCOCC1)C(=O)CCc1cccc2ccccc12.C[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)c1cnccn1)C(=O)CCc1cccc2ccccc12.Cc1ccc(S(=O)(=O)C[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)CCc2cccc3ccccc23)cc1
InChIInChI=1S/C30H34N2O5.C27H31N3O4.C27H30N2O5S.C26H33N3O5.C25H26N4O4.5C4H10O/c1-37-20-27(28(34)17-15-23-12-7-11-22-10-5-6-13-26(22)23)32-30(36)24(19-29(31)35)18-25(33)16-14-21-8-3-2-4-9-21;1-18(25(32)13-11-20-8-5-9-24-23(20)14-15-29-24)30-27(34)21(17-26(28)33)16-22(31)12-10-19-6-3-2-4-7-19;1-18-10-13-23(14-11-18)35(33,34)17-22(16-26(28)31)27(32)29-19(2)25(30)15-12-21-8-5-7-20-6-3-4-9-24(20)21;1-18(24(31)10-9-20-7-4-6-19-5-2-3-8-23(19)20)28-26(33)21(16-25(27)32)15-22(30)17-29-11-13-34-14-12-29;1-16(22(30)10-9-18-7-4-6-17-5-2-3-8-20(17)18)29-25(33)19(14-24(26)32)13-23(31)21-15-27-11-12-28-21;5*1-4(2,3)5/h2-13,24,27H,14-20H2,1H3,(H2,31,35)(H,32,36);2-9,14-15,18,21,29H,10-13,16-17H2,1H3,(H2,28,33)(H,30,34);3-11,13-14,19,22H,12,15-17H2,1-2H3,(H2,28,31)(H,29,32);2-8,18,21H,9-17H2,1H3,(H2,27,32)(H,28,33);2-8,11-12,15-16,19H,9-10,13-14H2,1H3,(H2,26,32)(H,29,33);5*5H,1-3H3/t24-,27-;18-,21-;19-,22+;18-,21-;16-,19-;;;;;/m00000...../s1
InChIKeyMGXQYNQOYHIQCE-BNWQGVBUSA-N
XLogP17.85
TPSA713.14 Ų
H-Bond Donors16
H-Bond Acceptors31
Rotatable Bonds62
Heavy Atoms198
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002743.47
LogP ≤ 517.85
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1031

Analyze (2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-N'-methyl-2-(3-morpholin-4-yl-2-oxopropyl)butanediamide
CID 160841387
(3S)-3-[[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]carbamoyl]-5-oxo-7-phenylheptanoic acid
CID 160778155
(2R)-N-[(2S,5R)-5-butyl-1-(1H-indol-3-yl)-3,6,7-trioxo-9-phenylnonan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide
CID 149260690
(2S)-4-methyl-2-[[(2R)-5-morpholin-4-yl-4-oxo-2-(2-phenylethyl)pentanoyl]amino]pentanoic acid;yttrium
CID 158647715
benzyl (2S,5S)-2-benzyl-7-methyl-5-[[(2R)-5-morpholin-4-yl-4-oxo-2-(2-phenylethyl)pentanoyl]amino]-4-oxooctanoate
CID 158055447
[(2R,4S)-4-[[(2R,5S)-2-benzyl-7-methyl-5-[[(2R)-5-morpholin-4-yl-4-oxo-2-(2-phenylethyl)pentanoyl]amino]-4-oxooctanoyl]amino]-2-hydroxy-2,6-dimethyl-3-oxoheptyl] 4-[[1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]triazol-4-yl]methoxy]benzenesulfonate
CID 157291830
tert-butyl (3R)-3-[[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]carbamoyl]-5-oxohexanoate
CID 159516656
benzyl (2R,5S)-5-[[(2S)-2-amino-4-phenylbutanoyl]amino]-2-benzyl-7-methyl-4-oxooctanoate;ethyl (2R,5S)-2-benzyl-7-methyl-5-[[(2R)-5-morpholin-4-yl-4-oxo-2-(2-phenylethyl)pentanoyl]amino]-4-oxooctanoate
CID 167614583
(2R,5S)-2-benzyl-7-methyl-5-[[(2S)-5-morpholin-4-yl-4-oxo-2-(2-phenylethyl)pentanoyl]amino]-4-oxooctanoic acid
CID 159333568
[(4S)-4-[[(2R,5S)-2-benzyl-7-methyl-5-[[(2R)-5-morpholin-4-yl-4-oxo-2-(2-phenylethyl)pentanoyl]amino]-4-oxooctanoyl]amino]-2-hydroxy-2,6-dimethyl-3-oxoheptyl] 4-[(1-methyltriazol-4-yl)methylcarbamoyl]benzenesulfonate
CID 153004320
methyl (2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-(pyrazine-2-carbonylamino)propanoyl]amino]-3-phenylpropanoate
CID 67285320
(2S)-N-[(2S)-3-methoxy-1-(naphthalen-1-ylmethylamino)-1-oxopropan-2-yl]-2-[(4-methylphenyl)sulfonylamino]butanediamide
CID 129094803

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide?
The IUPAC name of (2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide (CID 159563569) is (2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide.
What is the SMILES notation for (2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide?
The canonical SMILES for (2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide is CC(C)(C)O.CC(C)(C)O.CC(C)(C)O.CC(C)(C)O.CC(C)(C)O.COC[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)CCc1ccccc1)C(=O)CCc1cccc2ccccc12.C[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)CCc1ccccc1)C(=O)CCc1cccc2[nH]ccc12.C[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)CN1CCOCC1)C(=O)CCc1cccc2ccccc12.C[C@H](NC(=O)[C@H](CC(N)=O)CC(=O)c1cnccn1)C(=O)CCc1cccc2ccccc12.Cc1ccc(S(=O)(=O)C[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)CCc2cccc3ccccc23)cc1.
What is the InChIKey of (2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide?
The InChIKey is MGXQYNQOYHIQCE-BNWQGVBUSA-N. The full InChI is InChI=1S/C30H34N2O5.C27H31N3O4.C27H30N2O5S.C26H33N3O5.C25H26N4O4.5C4H10O/c1-37-20-27(28(34)17-15-23-12-7-11-22-10-5-6-13-26(22)23)32-30(36)24(19-29(31)35)18-25(33)16-14-21-8-3-2-4-9-21;1-18(25(32)13-11-20-8-5-9-24-23(20)14-15-29-24)30-27(34)21(17-26(28)33)16-22(31)12-10-19-6-3-2-4-7-19;1-18-10-13-23(14-11-18)35(33,34)17-22(16-26(28)31)27(32)29-19(2)25(30)15-12-21-8-5-7-20-6-3-4-9-24(20)21;1-18(24(31)10-9-20-7-4-6-19-5-2-3-8-23(19)20)28-26(33)21(16-25(27)32)15-22(30)17-29-11-13-34-14-12-29;1-16(22(30)10-9-18-7-4-6-17-5-2-3-8-20(17)18)29-25(33)19(14-24(26)32)13-23(31)21-15-27-11-12-28-21;5*1-4(2,3)5/h2-13,24,27H,14-20H2,1H3,(H2,31,35)(H,32,36);2-9,14-15,18,21,29H,10-13,16-17H2,1H3,(H2,28,33)(H,30,34);3-11,13-14,19,22H,12,15-17H2,1-2H3,(H2,28,31)(H,29,32);2-8,18,21H,9-17H2,1H3,(H2,27,32)(H,28,33);2-8,11-12,15-16,19H,9-10,13-14H2,1H3,(H2,26,32)(H,29,33);5*5H,1-3H3/t24-,27-;18-,21-;19-,22+;18-,21-;16-,19-;;;;;/m00000...../s1.
What are the key properties of (2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide?
(2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide has a molecular weight of 2743.47 g/mol, XLogP of 17.85, 62 rotatable bonds, 16 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(2S)-5-(1H-indol-4-yl)-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-N-[(2S)-1-methoxy-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-4-phenylbutyl)butanediamide;(2S)-2-[(4-methylphenyl)sulfonylmethyl]-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;pentakis(2-methylpropan-2-ol);(2S)-2-(3-morpholin-4-yl-2-oxopropyl)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]butanediamide;(2S)-N-[(2S)-5-naphthalen-1-yl-3-oxopentan-2-yl]-2-(2-oxo-2-pyrazin-2-ylethyl)butanediamide is sourced from PubChem (CID 159563569), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).